People

Health :: Abbott to Expand Presence in Lipid Management Market with Acquisition of Kos Pharmaceuticals

Abbott and Kos Pharmaceuticals, Inc. today announced a definitive agreement for Abbott to acquire Kos for $78 per share in cash, for a total transaction value of $3.7 billion, net of cash currently held by Kos. Based in Cranbury, N.J., Kos is a specialty pharmaceutical company that develops and markets proprietary medications for the treatment of chronic cardiovascular, metabolic and respiratory diseases. The company has a growing presence in the $20 billion lipid management market.

Restless Legs Syndrome :: Boehringer Ingelheim?s pramipexole for the treatment of Restless Legs Syndrome RLS

Boehringer Ingelheim announced today that the U.S. Food and Drug Administration (FDA) has approved pramipexole, a non-ergot dopamine agonist, for the treatment of moderate to severe primary Restless Legs Syndrome (RLS).1 This is an important milestone for pramipexole (Mirapexin? / Sifrol? / Mirapex?), which was already approved throughout the European Union in April 2006 for this second indication.

Rheumatoid Arthritis :: ORENCIA, abatacept demonstrate continued efficacy in adults with rheumatoid arthritis

Bristol-Myers Squibb Company (NYSE: BMY) today announced that two-year data from three Phase III pivotal trials demonstrate the long-term efficacy of ORENCIA? (abatacept) in adult patients with moderate to severe rheumatoid arthritis (RA) who have had an inadequate response to one or more disease-modifying anti-rheumatic drugs (DMARDs) such as methotrexate and TNF antagonists. The data also demonstrate that ORENCIA provided clinically meaningful improvements in multiple aspects of health-related quality of life and physical function, sustained improvements in pain and had a consistent safety and tolerability profile through two years of treatment. These data will be presented at the upcoming 2006 American College of Rheumatology (ACR) Annual Scientific Meeting.

Brain Injury :: Hospital discharge instructions for mild brain injury faulty

In a study published in a recent issue of Brain Injury, researchers at the University at Buffalo found that discharge sheets from 14 of 15 hospitals that were reviewed lacked at least one important sign of a possible hemorrhage. Ten of the hospitals were located in Western New York; five were located in southern Ontario, Canada.

Flu :: Next flu pandemic – What to do until the vaccine arrives?

Experts believe the world is overdue for influenza pandemic. However, unless effective action against pandemic flu is taken now, we are in “dire straits,” according to a paper published in the November 10 issue of Science. The articled titled, “Next Flu Pandemic: What to Do Until the Vaccine Arrives?,” calls for research during the regular season flu season to better understand the effectiveness of non-pharmaceutical interventions such as social distancing, hand washing, face masks, and the like.

Diabetes :: Diabetes epidemic in Asia – Lancet

Diabetes cases are increasing faster in Asia than in developed countries with people developing the metabolic disease at a younger age and suffering more complications, the Lancet said, citing researchers in South Korea.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | Health Newstrack